Kane Biotech Inc (KNE)

Ticker: KNE Exchange: CVE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Past 90 days

Past 90 days

Past 90 days

Past 90 days

Company data

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-01-23	2025-01-17	B Purchase	Huizinga, Robert Director of Issuer Non-Executive Director	60,000 0.10 CAD 4,168	60,000	0.10	CAD 6,000
2025-01-23	2025-01-17	B Purchase	Edwards, Marc Director of Issuer Non-Executive Director	2,000,000 +31.3% 0.10 CAD 138,920	2,000,000 +31.3%	0.10	CAD 200,000
2025-01-18	2025-01-17	B Purchase	Renaud, Philip Director of Issuer Non-Executive Director	1,000,000 +6.1% 0.10 CAD 69,460	1,000,000 +6.1%	0.10	CAD 100,000
2025-01-18	2025-01-17	B Purchase	Dupuis, Raymond David Eugene Senior Officer of Issuer Officer	100,000 +10.1% 0.10 CAD 6,946	100,000 +10.1%	0.10	CAD 10,000
2024-09-17	2024-09-13	B Purchase	Huizinga, Robert Director of Issuer Non-Executive Director	90,000 0.13 CAD 8,282	90,000	0.13	CAD 11,250
2024-09-12	2024-09-11	B Purchase	Renaud, Richard J. 10% Security Holder of Issuer Large shareholder	2,500,000 +17.1% 0.10 CAD 184,125	2,500,000 +17.1%	0.10	CAD 250,000
2024-06-25	2024-06-25	B Purchase	Edwards, Marc Director of Issuer Non-Executive Director	345,000 +5.9% 0.14 CAD 35,360	345,000 +5.9%	0.14	CAD 48,300
2024-04-22	2024-04-17	S Sale	Renaud, Philip Director of Issuer Non-Executive Director	2,000,000 -10.9% 0.13 CAD 188,006	2,000,000 -10.9%	0.13	CAD 260,000